ORLANDO, Fla. – There is positive news ahead of Thursday’s Food and Drug Administration meeting to debate the use of COVID-19 vaccines and whether the shots are ready for wide-spread distribution.Documents released by U.S.
regulators Tuesday confirmed that Pfizer’s vaccine was strongly protective against COVID-19 and appeared safe -- offering the world’s first detailed look at the evidence behind the shots.The positive FDA review sets the stage for a decision allowing the vaccine’s initial use within days.
FDA regulators posted their analysis online even as across the Atlantic, Britain began vaccinating its oldest citizens with the shots, which were co-developed with BioNTech.But the U.S.